tiprankstipranks
Trending News
More News >
Cutia Therapeutics (HK:2487)
:2487
Hong Kong Market

Cutia Therapeutics (2487) Financial Statements

Compare
2 Followers

Cutia Therapeutics Financial Overview

Cutia Therapeutics's market cap is currently HK$1.90B. The company's EPS TTM is HK$-0.8262505274999999; its P/E ratio is -3.20; Cutia Therapeutics is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 279.62M¥ 137.62M¥ 11.37M¥ 2.04M
Gross Profit¥ 143.46M¥ 71.01M¥ 7.94M¥ 1.61M
Operating Income¥ -455.15M¥ -539.65M¥ -309.20M¥ -179.99M
EBITDA¥ -430.69M¥ -1.92B¥ -535.19M¥ -309.23M
Net Income¥ -433.81M¥ -1.96B¥ -555.84M¥ -319.58M
Balance Sheet
Cash & Short-Term Investments¥ 876.15M¥ 1.27B¥ 1.08B¥ 1.38B
Total Assets¥ 1.39B¥ 1.71B¥ 1.45B¥ 1.49B
Total Debt¥ 320.94M¥ 243.75M¥ 54.13M¥ 26.53M
Net Debt¥ -64.73M¥ -229.37M¥ -411.74M¥ -176.60M
Total Liabilities¥ 418.51M¥ 357.76M¥ 2.69B¥ 2.29B
Stockholders' Equity¥ 974.73M¥ 1.35B¥ -1.25B¥ -790.51M
Cash Flow
Free Cash Flow¥ -468.66M¥ -437.23M¥ -371.50M¥ -185.76M
Operating Cash Flow¥ -442.98M¥ -381.31M¥ -236.19M¥ -159.88M
Investing Cash Flow¥ 316.07M¥ -203.58M¥ 462.06M¥ -410.65M
Financing Cash Flow¥ 37.84M¥ 588.32M¥ -10.25M¥ 480.76M
Currency in CNY

Cutia Therapeutics Earnings and Revenue History

Cutia Therapeutics Debt to Assets

Cutia Therapeutics Cash Flow

Cutia Therapeutics Forecast EPS vs Actual EPS